Financial report
|
|
|
|
|
|
H1 2021, kEUR |
API |
Related services |
Total |
|
|
|
|
|
|
Timing of transfer of goods and services |
|
|
|
|
Point in time |
126,353 |
|
126,353 |
|
Over time |
|
8,783 |
8,783 |
|
Total revenue |
126,353 |
8,783 |
135,136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H1 2020, kEUR |
API |
Related services |
Total |
|
|
|
|
|
|
Timing of transfer of goods and services |
|
|
|
|
Point in time |
78,988 |
|
78,988 |
|
Over time |
|
8,820 |
8,820 |
|
Total revenue |
78,988 |
8,820 |
87,808 |
Revenues from Active Pharmaceutical Ingredients (API) fully relate to the sale of goods and revenues from related services relate to the rendering of services. All revenues from contracts with customers classify as business-to-business.
|
|
|
|
|
kEUR |
H1 2021 |
H1 2020 |
|
|
|
|
|
Americas |
51,962 |
41,783 |
|
Europe |
75,340 |
38,433 |
|
Asia Pacific |
5,766 |
7,330 |
|
Others |
2,068 |
262 |
|
Total revenue |
135,136 |
87,808 |
Revenue is attributed to the individual geographical area based on the invoice address of the respective customer.